The merger is complete and the stock is delisted; no further trading in AVNS will occur. Shareholders who have not yet tendered should contact their broker regarding receipt of the $25.00 cash payment. The delisting is a formality with no residual market activity.
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The New York Stock Exchange filed a Form 25-NSE to delist Avanos Medical, Inc. (AVNS) following the completion of its going-private merger with A-AV MergerSub, Inc., an affiliate of American Industrial Partners. The merger closed on July 27, 2026, with each share of AVNS common stock converted into $25.00 in cash. Trading was suspended immediately, and delisting will be effective August 7, 2026.
Key Facts
- Merger closed July 27, 2026; each share of AVNS common stock converted into $25.00 cash.
- Trading suspended on NYSE as of July 27, 2026; delisting effective August 7, 2026.
- Acquirer is A-AV MergerSub, Inc., a wholly-owned subsidiary of A-AV Holdco I, Inc., affiliated with investment funds advised by American Industrial Partners.
- The filing is a procedural notification under Rule 12d2-2(a)(3) for securities that now represent only the right to receive cash.
Financial Impact
All outstanding shares of AVNS were acquired at $25.00 per share in cash, implying a total equity value of approximately $1.2B based on market cap.
Risk Factors
- No further trading opportunity; remaining unexchanged shares must be submitted for the cash consideration.
- Potential delays in receiving cash payment if shareholder records are not updated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0000876661-26-000646 |
| Document: 0000876661-26-000646-index.html | 0000876661-26-000646 |
| Document: 0000876661-26-000646.txt | 0000876661-26-000646 |
Track record
7 reports on AVNS
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +1.13% at T+60 after the Apr 23, 2026 report. 2 of 3 went positive at some point.
Filters
- Jul 27, 202616w ago 25-NSE Neutral 5/10 Viewing Entry $24.99 No price data
- Jul 2, 202619w ago 8-K / DEFA14A Bullish 7/10 Entry $24.93 to $24.94 ▲ +0.04% −0.89% vs SPY
- Jun 10, 202622w ago DEFM14A Bullish 8/10 Entry $24.98 to $24.87 ▼ −0.44% −0.87% vs SPY
- May 5, 202627w ago DEFA14A Neutral 5/10 Entry $24.72 to $24.73 ▲ +0.04% −1.09% vs SPY
- Apr 23, 202629w ago DEFA14A Bullish 8/10 Entry $24.71 to $24.65 ▼ −0.24% −1.72% vs SPY
- Apr 14, 202630w ago DEFA14A Neutral 4/10 Entry $24.63 to $24.64 ▲ +0.04% −1.35% vs SPY
- Feb 26, 202637w ago 8-K Neutral 5/10 Entry $14.49 to $13.79 ▼ −4.83% −3.70% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers